A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma
暂无分享,去创建一个
David A. Smith | D. V. Von Hoff | L. Marton | N. Vogelzang | J. Stephenson | R. Casero | D. Richards | C. Becerra | L. Garbo | R. Jotte | P. Conkling | T. Boyd | Michael L. Fitzgerald | T. Murray Stewart | Hillary H. Wu